These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1982710)

  • 41. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW; Ludvigsen NW; Cleland LG; Milazzo SC
    J Rheumatol; 1982; 9(4):532-5. PubMed ID: 6813469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

  • 43. History of the development of sulphasalazine in rheumatology.
    McConkey B
    Drugs; 1986; 32 Suppl 1():12-7. PubMed ID: 2877849
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
    Hurst NP; Bell AL; Nuki G
    Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered thiol status in patients with rheumatoid arthritis.
    Banford JC; Brown DH; Hazelton RA; McNeil CJ; Smith WE; Sturrock RD
    Rheumatol Int; 1982; 2(3):107-11. PubMed ID: 6819630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oscillations in bovine erythrocyte membrane free thiols.
    Gaczyńska M
    Cytobios; 1987; 51(205):71-9. PubMed ID: 3652737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of anti-arthritic gold compounds on mycoplasma and leishmania.
    Berkoff CE; Actor P; Sutton BM; Walz DT; Klinikowski N
    Arzneimittelforschung; 1974 Dec; 24(12):1988-90. PubMed ID: 4217631
    [No Abstract]   [Full Text] [Related]  

  • 49. Ultrastructural changes produced in rheumatoid synovial membrane by chrysotherapy.
    Ghadially FN; Oryschak AF; Mitchell DM
    Ann Rheum Dis; 1976 Feb; 35(1):67-72. PubMed ID: 818965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concentration and reactivity of the sulphydryl group population on the membrane of intact erythrocytes in patients with rheumatoid arthritis.
    Chilles C; Mulheron M; McCrae FM; Reglinksi J; Smith WE; Brzeski M; Sturrock RD
    Ann Rheum Dis; 1990 Sep; 49(9):668-71. PubMed ID: 2241282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro.
    Danis VA; Franic GM; Brooks PM
    Drugs Exp Clin Res; 1991; 17(12):549-54. PubMed ID: 1841047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.
    Rudge SR; Perrett D; Swannell AJ
    Ann Rheum Dis; 1984 Oct; 43(5):698-702. PubMed ID: 6437348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of gold salts treatment on the serum concentration of IL-1 and IL-2 in patients with rheumatoid arthritis.
    Lewandowicz J; Dabkowska B; Nowak D
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):195-8. PubMed ID: 8744695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulphydryl dependence of the inhibition of mitogen-induced human lymphocyte proliferation by sodium aurothiomalate.
    McCormack PL; Palmer DG
    Biochem Pharmacol; 1980 Dec; 29(24):3333-6. PubMed ID: 6783048
    [No Abstract]   [Full Text] [Related]  

  • 56. Sulphasalazine in the long term management of rheumatoid arthritis.
    Bax DE; Amos RS
    Drugs; 1986; 32 Suppl 1():73-6. PubMed ID: 2877858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter: Serum gold levels.
    Harth M
    Arthritis Rheum; 1975; 18(2):186-7. PubMed ID: 805594
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
    Crilly A; Madhok R; Watson J; Capell HA
    Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 60. Salazosulfapyridine and non-steroidal antiinflammatory drugs do not inhibit soybean lipoxygenase.
    Marcinkiewicz E; Duniec Z; Robak J
    Biochem Pharmacol; 1985 Jan; 34(1):148-9. PubMed ID: 2857082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.